{"id":"vin","safety":{"commonSideEffects":[{"rate":"40–50","effect":"Neutropenia"},{"rate":"20–30","effect":"Anemia"},{"rate":"10–20","effect":"Thrombocytopenia"},{"rate":"10–20","effect":"Peripheral neuropathy"},{"rate":"30–40","effect":"Nausea and vomiting"},{"rate":"20–30","effect":"Alopecia"},{"rate":"15–25","effect":"Constipation"}]},"_chembl":null,"_dailymed":{"setId":"b22e4c8e-dbe1-4d4b-a026-e1812974071c","title":"VINCRISTINE SULFATE INJECTION, SOLUTION [HOSPIRA, INC.]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Vinblastine binds to β-tubulin and prevents microtubule polymerization, which arrests cells in metaphase of mitosis. This leads to cell cycle arrest and programmed cell death in cancer cells. It is a classic chemotherapy agent with activity across multiple malignancies, particularly lymphomas and solid tumors.","oneSentence":"VIN (vinblastine) is a vinca alkaloid that inhibits microtubule assembly by binding to tubulin, thereby disrupting cell division and inducing apoptosis in rapidly dividing cells.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T02:11:33.665Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hodgkin lymphoma"},{"name":"Non-Hodgkin lymphoma"},{"name":"Testicular cancer"},{"name":"Breast cancer"},{"name":"Lung cancer"},{"name":"Sarcoma"}]},"trialDetails":[{"nctId":"NCT04881838","phase":"PHASE3","title":"CCCG-ALCL-2020 for Chinese Children and Adolescents With Newly Diagnosed High-risk ALCL","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Cancer Group, China","startDate":"2021-03-01","conditions":"Pediatric Anaplastic Large Cell Lymphoma","enrollment":172},{"nctId":"NCT02858310","phase":"PHASE1, PHASE2","title":"E7 TCR T Cells for Human Papillomavirus-Associated Cancers","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2017-01-27","conditions":"Papillomavirus Infections, Cervical Intraepithelial Neoplasia, Carcinoma In Situ","enrollment":224},{"nctId":"NCT05576831","phase":"NA","title":"STRatIfication of Vulvar Squamous Cell Carcinoma by HPV and p53 Status to Guide Excision","status":"RECRUITING","sponsor":"British Columbia Cancer Agency","startDate":"2024-11-25","conditions":"Vulvar Cancer","enrollment":249},{"nctId":"NCT05934851","phase":"NA","title":"A Study Evaluating the Effect of Frozen-Section Directed Excision Surgery on Vulvar Dysplasia","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2023-11-07","conditions":"Vulvar Neoplasm, Dysplasia Vulvar","enrollment":112},{"nctId":"NCT07229664","phase":"PHASE2, PHASE3","title":"Vinpocetine in Patients With Parkinsonian Disease","status":"RECRUITING","sponsor":"Tanta University","startDate":"2025-11-10","conditions":"Parkinson Disease","enrollment":60},{"nctId":"NCT07092007","phase":"NA","title":"NWRD09 for HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer","status":"RECRUITING","sponsor":"Newish Technology (Beijing) Co., Ltd.","startDate":"2024-06-05","conditions":"Intraepithelial Neoplasia, Cervical Cancer","enrollment":18},{"nctId":"NCT05104099","phase":"PHASE2","title":"Evaluation of New Diagnostic Tool Using Fluorescence to Detect High-grade Vulvar Intraepithelial Neoplasia","status":"COMPLETED","sponsor":"Institut de Cancérologie de Lorraine","startDate":"2021-11-29","conditions":"Vulvar Intraepithelial Neoplasia, Vulvar High Grade Squamous Intraepithelial Lesion, Differentiated Vulvar Intraepithelial Neoplasia","enrollment":17},{"nctId":"NCT02140021","phase":"NA","title":"Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and Cancer","status":"TERMINATED","sponsor":"M.D. Anderson Cancer Center","startDate":"2014-10-27","conditions":"Cervical Adenocarcinoma, Cervical Adenocarcinoma In Situ, Cervical Intraepithelial Neoplasia","enrollment":409},{"nctId":"NCT03811405","phase":"NA","title":"Physiology, Imaging and Modeling of Essential Tremor","status":"COMPLETED","sponsor":"University of Florida","startDate":"2021-04-01","conditions":"Essential Tremor, Parkinson Disease, Dystonia","enrollment":12},{"nctId":"NCT03061435","phase":"NA","title":"Screening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer.","status":"RECRUITING","sponsor":"Dr. Danielle Vicus","startDate":"2021-02-01","conditions":"Vulvar Cancer, Cervical Cancer, Vulvar Dysplasia","enrollment":110},{"nctId":"NCT03242616","phase":"PHASE2","title":"PemVin vs Vin in Previously Treated Metastatic Breast Cancer","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2017-02-17","conditions":"Breast Neoplasms","enrollment":17},{"nctId":"NCT03267680","phase":"PHASE2","title":"IRX-2 Regimen in Treating Women With Cervical Squamous Intraepithelial Neoplasia 3 or Squamous Vulvar Intraepithelial Neoplasia 3","status":"TERMINATED","sponsor":"University of Southern California","startDate":"2017-11-08","conditions":"Cervical Squamous Cell Carcinoma In Situ, Vulvar High Grade Squamous Intraepithelial Lesion","enrollment":10},{"nctId":"NCT05717621","phase":"PHASE1","title":"Clinical Trial With Local Decitabine Treatment of HPV-Induced VIN Grade 2/3 (DelVIN)","status":"COMPLETED","sponsor":"ViMREX GmbH","startDate":"2023-03-28","conditions":"Vulvar Intraepithelial Neoplasia Grade 2, Vulvar Intraepithelial Neoplasia Grade 3","enrollment":29},{"nctId":"NCT06798870","phase":"NA","title":"White Spot Lesions Development in Mixed Dentition Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mansoura University","startDate":"2024-07-02","conditions":"Anterior Functional Shift","enrollment":36},{"nctId":"NCT06741150","phase":"NA","title":"NWRD09 for HPV-16 Positive and HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer Patients.","status":"RECRUITING","sponsor":"Newish Technology (Beijing) Co., Ltd.","startDate":"2024-06-24","conditions":"Intraepithelial Neoplasia, Cervical Cancer","enrollment":18},{"nctId":"NCT03792516","phase":"PHASE1","title":"Artesunate Ointment for the Treatment of High Grade Vulvar Intraepithelial Neoplasia (HSIL VIN2/3)","status":"COMPLETED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2019-04-17","conditions":"Vulvar Dysplasia, HPV-Related Vulvar Intraepithelial Neoplasia, Preinvasive Vulvar Disease","enrollment":15},{"nctId":"NCT06297187","phase":"","title":"Cavitronic Ultrasonic Surgical Aspiration (CUSA) Women's Health Study","status":"COMPLETED","sponsor":"Integra LifeSciences Corporation","startDate":"2024-02-23","conditions":"Vulvar Intraepithelial Neoplasia, Condylomata Acuminata","enrollment":56},{"nctId":"NCT02735109","phase":"NA","title":"Interest of the Confocal Microscope in the Diagnosis of Epidermoid Carcinoma of the Vulva and Their Precursors","status":"TERMINATED","sponsor":"Centre Hospitalier Universitaire de Nice","startDate":"2015-04","conditions":"Vulvar Mucosa Lesions, Vulvar Intraepithelial Neoplasia","enrollment":10},{"nctId":"NCT02875561","phase":"NA","title":"Ultrasonic Aspiration Versus CO2 Laser Ablation for the Treatment of Vulvar Intraepithelial Neoplasia","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2017-03-26","conditions":"Vulvar Intraepithelial Neoplasia (VIN)","enrollment":47},{"nctId":"NCT03180684","phase":"PHASE2","title":"Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3)","status":"COMPLETED","sponsor":"Inovio Pharmaceuticals","startDate":"2017-08-31","conditions":"Vulvar High Grade Squamous Intraepithelial Lesion (HSIL), Vulvar Dysplasia, Vulvar Intraepithelial Neoplasia (VIN)","enrollment":33},{"nctId":"NCT05694728","phase":"PHASE2","title":"A Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV Vaccine","status":"COMPLETED","sponsor":"Beijing Health Guard Biotechnology, Inc","startDate":"2020-05-23","conditions":"Human Papilloma Virus Infection","enrollment":780},{"nctId":"NCT05680454","phase":"PHASE1","title":"A Phase I Trial Evaluate the Safety and Tolerability Profile of HPV Vaccine","status":"COMPLETED","sponsor":"Beijing Health Guard Biotechnology, Inc","startDate":"2019-09-01","conditions":"Human Papillomavirus Infection","enrollment":160},{"nctId":"NCT05668572","phase":"PHASE3","title":"A Phase III Trial Evaluates the Efficacy, Immunogenicity and Safety Profile of HPV Vaccine","status":"UNKNOWN","sponsor":"Beijing Health Guard Biotechnology, Inc","startDate":"2020-12-05","conditions":"Human Papillomavirus Infection","enrollment":12000},{"nctId":"NCT05662020","phase":"PHASE3","title":"A Study to Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Years in China","status":"ACTIVE_NOT_RECRUITING","sponsor":"Beijing Health Guard Biotechnology, Inc","startDate":"2022-03-23","conditions":"Human Papillomavirus Infection","enrollment":2750},{"nctId":"NCT02727387","phase":"PHASE2","title":"Protocol for the Treatment of Metastatic Ewing Sarcoma","status":"COMPLETED","sponsor":"Italian Sarcoma Group","startDate":"2009-06-01","conditions":"Ewing's Sarcoma (ES)","enrollment":155},{"nctId":"NCT05373628","phase":"NA","title":"Study on the Correlation Between the Quantitative Parameters of Mr Mean Cell Size Imaging and the Histopathological Characteristics of Breast Cancer","status":"UNKNOWN","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2022-05-11","conditions":"Breast Carcinoma; Magnetic Resonance Imaging；OGSE","enrollment":200},{"nctId":"NCT00394758","phase":"PHASE3","title":"A Randomized Trial of Surgical Treatments for Vulvar and Vaginal Dysplasia","status":"COMPLETED","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2000-01-01","conditions":"Vulvar Dysplasia, Vaginal Dysplasia","enrollment":150},{"nctId":"NCT05170620","phase":"NA","title":"Research of Laser Ablation for the Treatment of Lower Anogenital Tracts' Precancerous Lesions","status":"UNKNOWN","sponsor":"Tongji Hospital","startDate":"2019-11-08","conditions":"Squamous Intraepithelial Lesions, Laser Burn","enrollment":200},{"nctId":"NCT01861535","phase":"PHASE3","title":"Primary Imiquimod Treatment Versus Surgery for Vulvar Intraepithelial Neoplasia","status":"COMPLETED","sponsor":"Medical University of Graz","startDate":"2013-06","conditions":"Vulvar Intraepithelial Neoplasia","enrollment":110},{"nctId":"NCT01735006","phase":"PHASE3","title":"Efficacy and Immunogenicity Study of Recombinant Human Papillomavirus Bivalent（Type 16/18 ）Vaccine","status":"COMPLETED","sponsor":"Xiamen University","startDate":"2012-11-22","conditions":"Cervical Intraepithelial Neoplasia, Cervical Cancer, Vaginal Intraepithelial Neoplasia","enrollment":7372},{"nctId":"NCT03577834","phase":"NA","title":"The Effect of Vinegar Consumption on Visceral Fat and Blood Glucose Concentration","status":"COMPLETED","sponsor":"Carol Johnston","startDate":"2017-01-05","conditions":"Visceral Obesity, Tooth Erosion, Insulin Resistance","enrollment":102},{"nctId":"NCT00776724","phase":"PHASE3","title":"Tailored Neoadjuvant Chemotherapy for Stage II/III Breast Cancer With Tumor Size More Than 2 cm","status":"COMPLETED","sponsor":"National Taiwan University Hospital","startDate":"2008-05-29","conditions":"Breast Cancer, Chemotherapy","enrollment":166},{"nctId":"NCT02223975","phase":"","title":"Evaluation of the Role of Vibrational Spectroscopy in the Assessment of Vulval Disease","status":"SUSPENDED","sponsor":"Gloucestershire Hospitals NHS Foundation Trust","startDate":"2014-08","conditions":"Normal Vulval Skin, Lichen Sclerosus, High Grade Dysplasia - Usual Type ('VIN 2-3')","enrollment":200},{"nctId":"NCT02596074","phase":"PHASE2","title":"Pharmacodynamics, Safety/Tolerability and Efficacy of Topical Omiganan in Patients With uVIN","status":"COMPLETED","sponsor":"Maruho Co., Ltd.","startDate":"2015-11","conditions":"Usual Type Vulval Intraepithelial Neoplasia (uVIN)","enrollment":12},{"nctId":"NCT00842712","phase":"PHASE2","title":"Cilengitide and Cetuximab in Combination With Platinum-based Chemotherapy as First-line Treatment for Subjects With Advanced Non Small Cell Lung Cancer (NSCLC)","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2009-02","conditions":"Carcinoma, Non-Small-Cell Lung","enrollment":232},{"nctId":"NCT01986725","phase":"PHASE2","title":"The Impact of the \"WOMAN-PRO II Program\" on Patients With Vulvar Neoplasia to Minimize Post-surgical Symptom Prevalence","status":"COMPLETED","sponsor":"St.Gallen University of Applied Sciences","startDate":"2013-09","conditions":"Vulvar Cancer, Vulvar Intraepithelial Neoplasia","enrollment":45},{"nctId":"NCT00092521","phase":"PHASE3","title":"Cervical Intraepithelial Neoplasm (CIN)-Warts Efficacy Trial in Women (Gardasil)(V501-013)(COMPLETED)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2001-12","conditions":"Cervical Cancer, Genital Warts","enrollment":5759},{"nctId":"NCT00941811","phase":"PHASE2","title":"Immunevasion of Human Papillomavirus (HPV) in Vulvar Intraepithelial Neoplasia 2/3 and Anogenital Warts and Efficiency and Mechanisms of Imiquimod Treatment","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2008-12","conditions":"HPV","enrollment":5},{"nctId":"NCT01676792","phase":"EARLY_PHASE1","title":"SR-T100 Gel Efficacy & Safety Study for Vulva Pre-cancerous Lesions & Cutaneous Condyloma","status":"COMPLETED","sponsor":"National Cheng-Kung University Hospital","startDate":"2011-04","conditions":"Vulvar Intraepithelial Neoplasia, Genital Warts","enrollment":29},{"nctId":"NCT01313104","phase":"NA","title":"Colposcopy and High Resolution Anoscopy in Screening For Anal Dysplasia in Patients With Cervical, Vaginal, or Vulvar Dysplasia or Cancer","status":"WITHDRAWN","sponsor":"Northwestern University","startDate":"","conditions":"Cervical Intraepithelial Neoplasia Grade 1, Cervical Intraepithelial Neoplasia Grade 2, Cervical Intraepithelial Neoplasia Grade 3","enrollment":""},{"nctId":"NCT00755014","phase":"PHASE1","title":"Study Effect of Red Wine Consumption on Endothelial Progenitor Cells and Endothelial Function","status":"COMPLETED","sponsor":"Taipei Veterans General Hospital, Taiwan","startDate":"2007-09","conditions":"Endothelial Progenitor Cells Numbers, Endothelial Function (FMD)","enrollment":40}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1387,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Vincristine"],"phase":"marketed","status":"active","brandName":"VIN","genericName":"VIN","companyName":"Italian Sarcoma Group","companyId":"italian-sarcoma-group","modality":"Small molecule","firstApprovalDate":"","aiSummary":"VIN (vinblastine) is a vinca alkaloid that inhibits microtubule assembly by binding to tubulin, thereby disrupting cell division and inducing apoptosis in rapidly dividing cells. Used for Hodgkin lymphoma, Non-Hodgkin lymphoma, Testicular cancer.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}